About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 591313, 6 pages
http://dx.doi.org/10.1155/2013/591313
Research Article

Aqueous Extract of Annona macroprophyllata: A Potential α-Glucosidase Inhibitor

1Unidad de Biomedicina, Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Avenida de los Barrios 1, Los Reyes Iztacala, 54090 Tlalnepantla, MEX, Mexico
2Laboratorio de Neurofarmacología de Productos Naturales de la Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calzada México-Xochimilco 101, Colonia San Lorenzo Huipulco, 14370 México City, DF, Mexico
3Instituto Nacional de Medicina Genómica (INMEGEN), Periférico sur 4809, Arenal Tepepan, Tlalpan, Secretaría de Salud, 14610 México City, DF, Mexico
4Departamento de Ecología y Recursos Naturales Facultad de Ciencias, Universidad Nacional Autónoma de México, Ciudad Universitaria Coyoacán, 04510 México City, DF, Mexico

Received 29 April 2013; Accepted 25 July 2013

Academic Editor: Ruth C. R. Meex

Copyright © 2013 F. Brindis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global prevalence of diabetes: estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–1053, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Kerner and J. Brückel, “Definition, classification, and diagnosis of diabetes mellitus,” Diabetologie und Stoffwechsel, vol. 4, no. 2, pp. S115–S117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Bonora and M. Muggeo, “Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence,” Diabetologia, vol. 44, no. 12, pp. 2107–2114, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Ceriello, “Postprandial hyperglycemia and diabetes complications: is it time to treat?” Diabetes, vol. 54, no. 1, pp. 1–7, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Quezada-Calvillo, C. C. Robayo-Torres, A. R. Opekun et al., “Contribution of mucosal maltase-glucoamylase activities to mouse small intestinal starch α-glucogenesis,” Journal of Nutrition, vol. 137, no. 7, pp. 1725–1733, 2007. View at Scopus
  6. A. J. Krentz and C. J. Bailey, “Oral antidiabetic agents,” Drugs, vol. 65, no. 3, pp. 385–411, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Borges de Melo, A. da Silveira Gomes, and I. Carvalho, “α- and β-glucosidase inhibitors: chemical structure and biological activity,” Tetrahedron, vol. 62, no. 44, pp. 10277–10302, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Bischoff, W. Puls, H. P. Krause, H. Schutt, and G. Thomas, “Pharmacological properties of the novel glucosidase inhibitors BAY m 1099 (miglitol) and BAY o 1248,” Diabetes Research and Clinical Practice, vol. 1, pp. 53–62, 1985.
  9. A. Horii, M. Emi, N. Tomita et al., “Primary structure of human pancreatic α-amylase gene: its comparison with human salivary α-amylase gene,” Gene, vol. 60, no. 1, pp. 57–64, 1987. View at Publisher · View at Google Scholar · View at Scopus
  10. Y.-I. Kwon, E. Apostolidis, and K. Shetty, “In vitro studies of eggplant (Solanum melongena) phenolics as inhibitors of key enzymes relevant for type 2 diabetes and hypertension,” Bioresource Technology, vol. 99, no. 8, pp. 2981–2988, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. J. Cañizares, Las Frutas Anonáceas, Ediciones Fruticus, La Habana, Cuba, 1966.
  12. S. E. Ruiz and A. L. Morett, Las Anonas en el México Prehispánico. Memorias Congreso Internacional de Anonáceas. Chapingo, Estado de México, 169-186, 1997.
  13. W. Popenoe, Manual of Tropical and Sub-Tropical Fruits, Hafner Press, New York, NY, USA, 1920.
  14. M. E. González-Trujano, A. Navarrete, B. Reyes, and E. Hong, “Some pharmacological effects of the ethanol extract of leaves of Annona diversifolia on the central nervous system in mice,” Phytotherapy Research, vol. 12, pp. 600–602, 1998.
  15. M. E. González-Trujano, A. Navarrete, B. Reyes, E. Cedillo-Portugal, and E. Hong, “Anticonvulsant properties and bio-guided isolation of palmitone from leaves of Annona diversifolia,” Planta Medica, vol. 67, no. 2, pp. 136–141, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. M. E. González-Trujano, E. Tapia, L. López-Meraz, A. Navarrete, A. Reyes-Ramírez, and A. Martínez, “Anticonvulsant effect of Annona diversifolia Saff. and palmitone on penicillin-induced convulsive activity. A behavioral and EEG study in rats,” Epilepsia, vol. 47, no. 11, pp. 1810–1817, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. I. Carballo, A. L. Martínez, M. E. González-Trujano et al., “Antinociceptive activity of Annona diversifolia Saff. leaf extracts and palmitone as a bioactive compound,” Pharmacology Biochemistry and Behavior, vol. 95, no. 1, pp. 6–12, 2010. View at Publisher · View at Google Scholar
  18. A. Andrade-Cetto and M. Heinrich, “Mexican plants with hypoglycaemic effect used in the treatment of diabetes,” Journal of Ethnopharmacology, vol. 99, no. 3, pp. 325–348, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Shirwaikar, K. Rajendran, C. Dinesh Kumar, and R. Bodla, “Antidiabetic activity of aqueous leaf extract of Annona squamosa in streptozotocin-nicotinamide type 2 diabetic rats,” Journal of Ethnopharmacology, vol. 91, no. 1, pp. 171–175, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. D. O. Adeyemi, O. A. Komolafe, O. S. Adewole, et al., “Anti hyperglycemic activities of Annona muricata (Linn),” African Journal of Traditional, Complementary and Alternative Medicines, vol. 6, no. 1, pp. 62–69, 2009. View at Scopus
  21. S. Cristians, J. A. Guerrero-Analco, A. Pérez-Vásquez et al., “Hypoglycemic activity of extracts and compounds from the leaves of Hintonia standleyana and H. latiflora: potential alternatives to the use of the stem bark of these species,” Journal of Natural Products, vol. 72, no. 3, pp. 408–413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. K. Gupta, A. N. Kesari, P. S. Murthy, R. Chandra, V. Tandon, and G. Watal, “Hypoglycemic and antidiabetic effect of ethanolic extract of leaves of Annona squamosa L. in experimental animals,” Journal of Ethnopharmacology, vol. 99, no. 1, pp. 75–81, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. R. K. Gupta, A. N. Kesari, S. Diwakar et al., “In vivo evaluation of anti-oxidant and anti-lipidimic potential of Annona squamosa aqueous extract in type 2 diabetic models,” Journal of Ethnopharmacology, vol. 118, no. 1, pp. 21–25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Gupta-Elera, A. R. Garrett, A. Martinez, R. A. Robison, and K. L. O'Neill, “The antioxidant properties of the cherimoya (Annona cherimola) fruit,” Food Research International, vol. 44, no. 7, pp. 2205–2209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. R. Loizzo, R. Tundis, M. Bonesi et al., “Radical scavenging, antioxidant and metal chelating activities of Annona cherimola Mill. (cherimoya) peel and pulp in relation to their total phenolic and total flavonoid contents,” Journal of Food Composition and Analysis, vol. 25, no. 2, pp. 179–184, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Kamalakkannan and P. S. Mainzen Prince, “Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues,” Molecular and Cellular Biochemistry, vol. 293, no. 1-2, pp. 211–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. A. A. Henrique Fernandes, E. L. Barbosa Novelli, K. Okoshi et al., “Influence of rutin treatment on biochemical alterations in experimental diabetes,” Biomedicine and Pharmacotherapy, vol. 64, no. 3, pp. 214–219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. O. Hnatyszyn, J. Miño, G. Ferraro, and C. Acevedo, “The hypoglycemic effect of Phyllanthus sellowianus fractions in streptozotocin-induced diabetic mice,” Phytomedicine, vol. 9, no. 6, pp. 556–559, 2002. View at Scopus
  29. O. M. Ahmed, A. A. Moneim, I. A. Yazid, and A. M. Mahmoud, “Antihyperglycemic, antihyperlipidemic and antioxidant effects and the probable mechanisms of action of Ruta graveolens infusion and rutin in nicotinamide-streptozotocin-induced diabetic rats,” Diabetologia Croatica, vol. 39, no. 1, pp. 15–35, 2010. View at Scopus
  30. D. Fontana Pereira, L. H. Cazarolli, C. Lavado et al., “Effects of flavonoids on α-glucosidase activity: potential targets for glucose homeostasis,” Nutrition, vol. 27, no. 11-12, pp. 1161–1167, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Adisakwattana, S. Yibchok-Anun, P. Charoenlertkul, and N. Wongsasiripat, “Cyanidin-3-rutinoside alleviates postprandial hyperglycemia and its synergism with acarbose by inhibition of intestinal α-glucosidase,” Journal of Clinical Biochemistry and Nutrition, vol. 49, no. 1, pp. 36–41, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Pashikanti, D. R. de Alba, G. A. Boissonneault, and D. Cervantes-Laurean, “Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products,” Free Radical Biology and Medicine, vol. 48, no. 5, pp. 656–663, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Qin, F. Chao, F. Gao, et al., “Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of α-glucosidase,” Journal of Agricultural and Food Chemistry, vol. 57, no. 24, pp. 11463–11468, 2009. View at Publisher · View at Google Scholar · View at Scopus